{
    "2021-01-18": [
        [
            {
                "time": "",
                "original_text": "GICS行业巡礼】61家“医疗保健设备”行业沪深港上市公司初筛选",
                "features": {
                    "keywords": [
                        "GICS",
                        "医疗保健设备",
                        "沪深港",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健设备"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：假如市场风格切换 如何把握医药二线机会？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "市场风格切换",
                        "二线机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：中国创新药是否到了国际化的拐点？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中国创新药",
                        "国际化",
                        "拐点"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "创业板指涨超2%，英科医疗、蓝思科技涨超9%",
                "features": {
                    "keywords": [
                        "创业板指",
                        "英科医疗",
                        "蓝思科技",
                        "涨超"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "创业板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【银河医药孟令伟/刘晖】行业点评丨中国医用物资出口或长期受益于全球缺口",
                "features": {
                    "keywords": [
                        "银河医药",
                        "医用物资出口",
                        "全球缺口",
                        "长期受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}